Report / Trial registry metadata
Evaluation for NCI Surgery Branch Clinical Research Protocols
This study concerns Synovial Cell Cancer, Melanoma, Colorectal Cancer, Lung Cancer, Bladder Cancer. Its registered status is recruiting. The planned measures below describe the study design, not demonstrated treatment effects.
What is being studied?
- Conditions
- Synovial Cell Cancer, Melanoma, Colorectal Cancer, Lung Cancer, Bladder Cancer
- Study type
- Observational
How is the study designed?
- Enrollment
- 7000 (estimated)
- Minimum age
- 18 Years
- Eligibility sex
- All
What will the study measure?
- Number of individuals suitable for NCI Surgery Branch clinical research protocols Assessment window: 25 Years
- Frequency of HLA type, gene specific mutations, or expression of neoantigens in malignant tumors Assessment window: 25 years
- Results of screening tests Assessment window: 25 years
What can this record establish?
These are registered plans and status information. Enrollment marked estimated is a target, not a verified count of participants already studied. The measures listed do not establish that an intervention succeeded. Eligibility criteria and recruitment status must be checked against the full study record before considering participation.
- Kind
- Trial registry metadata
- Identifier
- NCT00001823
- Status
- RECRUITING